Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
|
|
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) Eigenschaften
- Siedepunkt:
- 616.5±55.0 °C(Predicted)
- Dichte
- 1.384±0.06 g/cm3(Predicted)
- pka
- 6.43±0.50(Predicted)
Sicherheit
HS Code | 2933497050 |
---|
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) Chemische Eigenschaften,Einsatz,Produktion Methoden
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 18)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 |
sales@chem-strong.com | China | 18070 | 56 |
Beijing Solarbio Science & Tecnology Co., Ltd. | 010-50973186 4009686088 |
3193328036@qq.com | China | 18338 | 68 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8706 | 55 |
Jinan Ruisi Pharmaceutical Technology Co., LTD | 0531-69900633 18340090523 |
changyuan20@163.com | China | 2670 | 58 |
Tianjin shijia biomedical technology co., LTD | 15022261580 |
tjshj1212@163.com | China | 2520 | 58 |
Shandong WorldSun Biological Technology Co., Ltd. | 0531-88723173 18596073690 |
1047208234@qq.com | China | 4899 | 58 |
Changzhou Xianglong Pharmaceutical Technology Co., LTD | 0519-88910898 18661161657 |
yaoxiangqiu2021@163.com | China | 9996 | 58 |
Shanghai YuZn Pharm. Technology Co.,Ltd. | 15921286451; 15921286451 |
2010681527@qq.com | China | 5115 | 58 |
Nanjing Huanuo Biomedical Technology Co., Ltd | 18913906212 |
2885426135@qq.com | China | 7160 | 58 |
- MOXIFLOXACIN RELATED COMPOUND F
- Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-1-methyl-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-
- USP Moxifloxacin Related Compound F
- Moxifloxacin Impurity 90
- Moxifloxacin Related Compound FQ: What is Moxifloxacin Related Compound F Q: What is the CAS Number of Moxifloxacin Related Compound F Q: What is the storage condition of Moxifloxacin Related Compound F
- 1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
- 1179992-99-4